Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor.

BACKGROUND Autologous recellularization of decellularized heart valve scaffolds is a promising challenge in the field of tissue-engineered heart valves and could be boosted by bone marrow progenitor cell mobilization. The aim of this study was to examine the spontaneous in vivo recolonization potential of xenogeneic decellularized heart valves in a lamb model and the effects of granulocyte colony-stimulating factor mobilization of bone marrow cells on this process. METHODS Decellularized porcine aortic valves were implanted in 12 lambs. Six lambs received granulocyte colony-stimulating factor (10 microg x kg(-1) x d(-1) for 7 days, granulocyte colony-stimulating factor group), and 6 received no granulocyte colony-stimulating factor (control group). Additionally, nondecellularized porcine valves were implanted in 5 lambs (xenograft group). Angiographic and histologic evaluation was performed at 3, 6, 8, and 16 weeks. RESULTS Few macroscopic modifications of leaflets and the aortic wall were observed in the control group, whereas progressive shrinkage and thickening of the leaflets appeared in the granulocyte colony-stimulating factor and xenograft groups. In the 3 groups progressive ovine cell infiltration (fluorescence in situ hybridization) was observed in the leaflets and in the adventitia and the intima of the aortic wall but not in the media. Neointimal proliferation of alpha-actin-positive cells, inflammatory infiltration, adventitial neovascularization, and calcifications were more important in the xenograft and the granulocyte colony-stimulating factor groups than in the control group. Continuous re-endothelialization appeared only in the control group. CONCLUSION Decellularized xenogeneic heart valve scaffolds allowed partial autologous recellularization. Granulocyte colony-stimulating factor led to accelerated heart valve deterioration similar to that observed in nondecellularized xenogeneic cardiac bioprostheses.

[1]  H. Gulbins,et al.  Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves. , 2003, The Journal of thoracic and cardiovascular surgery.

[2]  T. Wedel,et al.  Histopathologic findings in a novel decellularized pulmonary homograft: an autopsy study. , 2005, The Annals of thoracic surgery.

[3]  John Fisher,et al.  Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. , 2002, The Journal of heart valve disease.

[4]  E Wolner,et al.  Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  H. Matsubara,et al.  Macrophage Colony‐Stimulating Factor (M‐CSF), As Well As Granulocyte Colony‐Stimulating Factor (G‐CSF), Accelerates Neovascularization , 2005, Stem cells.

[6]  H. Sievers,et al.  Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  J. Fisher,et al.  Biocompatibility and recellularization potential of an acellular porcine heart valve matrix. , 2005, The Journal of heart valve disease.

[8]  W G Henderson,et al.  A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1993, The New England journal of medicine.

[9]  A Haverich,et al.  Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue , 2000, Circulation.

[10]  Hyun-Jai Cho,et al.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial , 2004, The Lancet.

[11]  Ernst Wolner,et al.  Tissue Engineering of Heart Valves: Decellularized Porcine and Human Valve Scaffolds Differ Importantly in Residual Potential to Attract Monocytic Cells , 2005, Circulation.

[12]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[13]  J. P. McCoy,et al.  Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[14]  H. Okano,et al.  Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. , 2004, Blood.

[15]  Michael Sacks,et al.  Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves. , 2003, The Annals of thoracic surgery.

[16]  W. Chitwood,et al.  Video-assisted and robotic mitral valve surgery: toward an endoscopic surgery. , 1999, Seminars in thoracic and cardiovascular surgery.

[17]  P. Merlet,et al.  Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. , 2003, Blood.

[18]  Ernst Wolner,et al.  Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. , 2004, The Journal of thoracic and cardiovascular surgery.

[19]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  John Fisher,et al.  Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. , 2002, The Journal of heart valve disease.

[21]  R. Anthony,et al.  Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens. , 2005, The Journal of heart valve disease.

[22]  C K Breuer,et al.  Tissue engineering heart valves: valve leaflet replacement study in a lamb model. , 1995, The Annals of thoracic surgery.

[23]  L. Sauvage,et al.  Administration of granulocyte colony-stimulating factor enhances endothelialization and microvessel formation in small-caliber synthetic vascular grafts. , 2000, Journal of vascular surgery.

[24]  F J Schoen,et al.  Functional Living Trileaflet Heart Valves Grown In Vitro , 2000, Circulation.

[25]  M. Pepys,et al.  Relationship of granulocyte colony stimulating factor with other acute phase reactants in man , 2005, Clinical and experimental immunology.

[26]  F J Schoen,et al.  Tissue-engineered valved conduits in the pulmonary circulation. , 2000, The Journal of thoracic and cardiovascular surgery.

[27]  R. Champlin,et al.  Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. , 1996, Blood.

[28]  I. Komuro,et al.  Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine. , 2004, Biochemical and biophysical research communications.

[29]  Simon P. Hoerstrup,et al.  Tissue Engineering of Functional Trileaflet Heart Valves From Human Marrow Stromal Cells , 2002, Circulation.

[30]  M. Arai,et al.  Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony–Stimulating Factor Treatment , 2004, Circulation.